Inovio Pharmaceuticals, Inc. (NASDAQ: INO) had its price target lowered by analysts at Royal Bank of Canada from $8.00 to $7.00. They now have a "sector perform" rating on the stock.
MediumReport
Inovio Pharmaceuticals, Inc. (NASDAQ: INO) had its price target lowered by analysts at Royal Bank of Canada from $8.00 to $7.00. They now have a "sector perform" rating on the stock.
Inovio Pharmaceuticals, Inc. (NASDAQ: INO) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $40.00 to $33.00. They now have an "outperform" rating on the stock.
LowReport
Inovio Pharmaceuticals, Inc. (NASDAQ: INO) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $40.00 to $33.00. They now have an "outperform" rating on the stock.
Inovio Pharmaceuticals, Inc. (NASDAQ: INO) had its price target lowered by analysts at Royal Bank of Canada from $11.00 to $8.00. They now have a "sector perform" rating on the stock.
LowReport
Inovio Pharmaceuticals, Inc. (NASDAQ: INO) had its price target lowered by analysts at Royal Bank of Canada from $11.00 to $8.00. They now have a "sector perform" rating on the stock.
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Don’t Miss Out On The Next BIG Stock Move
"Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ blog email newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our blog below: